Study of Immediate Start of Progestin Contraceptives in Medical Abortion

This study will compare immediate to post-abortion start of two progestin-based contraceptives (DMPA and etonorgestrel implants) among women having first trimester medical abortion who wish to use that method for post-abortion contraception.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Contraception

Sex eligibility

Female

Study type

Interventional

Phase

Phase 4

Primary location

Centro de Salud Beatriz Velasco de Aleman, Mexico City, Mexico

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Women having medical abortion desiring progestin-based contraceptives (injectables or implants)

Treatment and study plan

Timing of Contraceptive Initiation in Medical Abortion

Other

Primary outcomes

Medical Abortion Failure

Time frame: One month after enrollment
Repeat Pregnancy

Time frame: 6 months after enrollment

Sponsors and collaborators

Lead sponsor

Gynuity Health Projects

Other

Registry information

Official study title

Immediate Initiation of Progestin Contraceptives in First Trimester Medical Abortion: A Randomized Controlled Trial

Acronym: Quickstart

Important dates

Study start: 2013
Primary completion: 2015
Study completion: 2015
First posted: Jul 18, 2013
Registry last updated: Mar 4, 2016

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed